Dec 2, 2025, 09:51
Time to Refocus on NSTEMI․ Why This State-of-the-Art Review Matters
Davide Capodanno, Professor of Cardiology at University of Catania, editor-in-Chief of EuroIntervention, shared on X:
”We always talk about STEMI—and rightly so—but shouldn’t we also focus on NSTEMI? It is no less challenging; in fact, in several respects it is even more complex, as patients are typically older, more often multivessel, and clinically more difficult to manage. This is why this state-of-the-art review on the diagnosis, risk stratification, and early management of non–ST-segment elevation acute coronary syndromes, in my view, deserves careful reading. ”
Find more information here.
Find more posts on Hemostasis Today.
-
Jun 3, 2026, 13:51Ton Lisman: ISTH Opens Applications for Leadership Roles in Liver Disease Research
-
Jun 3, 2026, 13:41Abhishek Jain: New Microphysiological Model Sheds Light on COVID-19 Vascular Complications
-
Jun 3, 2026, 13:26M Shujat Rasool: DVT Red Flags Every Clinician Should Know
-
Jun 3, 2026, 09:14Wolfgang Miesbach: How Should We Monitor FVIII Expression After AAV5-Based Gene Therapy?
-
Jun 3, 2026, 09:02June Giddings: Giddings Strong Foundation Website Is Now Live
-
Jun 3, 2026, 08:47Alba Grayston Morales: How IL-1 Signaling Drives Injury and Repair in The Ischaemic Brain
-
Jun 3, 2026, 08:32Rob Maloney: Over 104,000 USD Raised at The 2026 Trot to Clot
-
Jun 3, 2026, 08:27Leonard Valentino: Why Clear Communication Matters in the Era of Gene Editing
-
Jun 3, 2026, 08:15Wolfgang Miesbach: When to Stop Anticoagulation after AF Ablation in 2026?